PCVX.NASDAQVaxcyte, INC

Form 4: Vaxcyte CFO Andrew Guggenhime Reports Stock Transactions

Sentiment:

SEC Form 4

📋All filings for Vaxcyte, INC
🔒Login to Follow

Andrew Guggenhime, CFO of Vaxcyte, Inc., reports acquisition and disposal of common stock and stock options.

Summary

  • Andrew Guggenhime, the President and CFO of Vaxcyte, Inc., filed a Form 4 detailing changes in beneficial ownership.
  • On February 27, 2025, Guggenhime acquired 22,761 shares of common stock related to restricted stock units (RSUs) at $0.
  • On the same day, Guggenhime acquired 75,991 stock options with an exercise price of $74.22, vesting over time until February 26, 2035.
  • On February 28, 2025, 1,270 shares of common stock were disposed of at $73.02 to cover tax withholding obligations.
  • On March 3, 2025, 3,809 shares of common stock were disposed of at $72.1 to cover tax withholding obligations.
  • Following these transactions, Guggenhime directly owns 127,173 shares of common stock and 75,991 stock options.

Sentiment

Score: 5

Explanation: This is a routine filing; the transactions are related to compensation and tax obligations, and do not necessarily indicate a positive or negative outlook.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.

Key Dates

DateDescription
02/27/2025Acquisition of 22,761 common stock shares via RSUs and 75,991 stock options.
02/28/2025Disposal of 1,270 common stock shares for tax withholding.
03/03/2025Disposal of 3,809 common stock shares for tax withholding.
03/03/2025Date of Form 4 filing.
02/26/2035Expiration date of stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.